Etude de marché - SANTE - SCIENCES DE LA VIE

Mon compte | Mon panier (0) | Contactez-nous | Abonnez-vous !

Résultats 531 - 540 de 4,550 sur 62 éditeurs

RSS_US

RSS_FR

Nursing Homes in Australia
Ibisworld \| 39 pages \| Septembre 2006 \| Anglais
This is the replacement to IBISWorld's August 2006 edition of Nursing Homes in Australia report.This report from IBISWorld provides a detailed analysis of the Nursing Homes industry in Australia, incl ...	515,00 €

Obesity Therapeutics: Understanding market dynamics (presentation)
Datamonitor \| 21 pages \| Avril 2007 \| Anglais
IntroductionObesity Therapeutics: Understanding Market Dynamics, a presentation given by Datamonitor at the Obesity Drug Development Summit in July 2006.ScopeAn overview of the obesity epidemic given ...	4.556,00 €

GSK's Cervarix - a future blockbuster of 2007
Visiongain \| 86 pages \| Mars 2007 \| Anglais
The number of blockbusters continues to increase. The number is set to increase to 112 in 2007. Of the products set to receive FDA approval this year and generate blockbuster status on an annual ...	3.000,00 €

Chinese Pharmaceutical Sector: Industry Profile
Koncept Analytics \| 25 pages \| Juin 2008 \| Anglais
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and ana ...	480,00 €

Japan's Medical Device Market Size, 1997-2003
TriMark \| 1 page \| Janvier 2006 \| Anglais
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...	80,00 €

Pipeline Insight: Osteoarthritis - The Wait for a DMOAD Continues
Datamonitor \| 199 pages \| Novembre 2006 \| Anglais
IntroductionOsteoarthritis (OA) is characterized by the progressive destruction of articular joints and is a major cause of pain in Western populations. Osteoarthritis is the most common form of a ...	9.690,00 €

05-032: The RNA Purification Market: Evaluating Competitive Dynamics & Establishing Benchmarks
BioInformatics \| 186 pages \| Juin 2005 \| Anglais
This report details researchers' experimental parameters and uses for purified RNA, current and future levels of sample throughput and the purification methods used ...	1.920,00 €

AstraZeneca plc: PharmaVitae Profile
Datamonitor \| 174 pages \| Juillet 2008 \| Anglais
IntroductionThis analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipel ...	4.560,00 €

Therapeutic Monoclonal Antibodies, 2006-2011 – Maximising the Growth Potential of a Stocked Pipeline
Visiongain \| 117 pages \| Décembre 2006 \| Anglais
While the pharmaceutical as a whole is suffering from single digit growth, thin uninspiring pipelines and pressure from an ever-aggressive generics industry – not so for monoclonal antibody therapies. ...	3.000,00 €

Contract Drug Discovery Industry
TriMark \| 4 pages \| Mars 2006 \| Anglais
The``Sector Snapshot`` is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This Sector Snapshot covers the outsourcing ...	160,00 €

1	\|	2	\|	3	\|	4	\|	5	\|	6	\|	7	\|	8	\|	9	\|	10	\|	11	\|	12	\|	13	\|	14	\|	15	\|	16	\|	17	\|	18	\|	19	\|	20	\|	21	\|	22	\|	23	\|	24	\|	25	\|
26	\|	27	\|	28	\|	29	\|	30	\|	31	\|	32	\|	33	\|	34	\|	35	\|	36	\|	37	\|	38	\|	39	\|	40	\|	41	\|	42	\|	43	\|	44	\|	45	\|	46	\|	47	\|	48	\|	49	\|	50	\|
51	\|	52	\|	53	\|	54	\|	55	\|	56	\|	57	\|	58	\|	59	\|	60	\|	61	\|	62	\|	63	\|	64	\|	65	\|	66	\|	67	\|	68	\|	69	\|	70	\|	71	\|	72	\|	73	\|	74	\|	75	\|
76	\|	77	\|	78	\|	79	\|	80	\|	81	\|	82	\|	83	\|	84	\|	85	\|	86	\|	87	\|	88	\|	89	\|	90	\|	91	\|	92	\|	93	\|	94	\|	95	\|	96	\|	97	\|	98	\|	99	\|	100	\|
>>

CIPLS